Acute myocardial infarction and kidney function


Cite item

Full Text

Abstract

Frequency and prognostic significance of renal function deterioration in acute myocardial infarction are discussed. Approaches for diagnosis of renal failure in acute myocardial infarction and for treatment of such patients are shown

References

  1. Culleton BF, Larson MG, Evans JC et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 1999; 159: 1785-1790.
  2. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-2219
  3. Ronco C., House A.A., Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34: 957-962
  4. Meisinger C., Döring A., Löwel H.; KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur. Heart J. 2006; 27(10): 1245-1250
  5. Wright R.S., Reeder G.S., Herzog C.A. et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137(7): 563-570
  6. Gibson C.M., Dumaine R.L., Gelfand E.V. et al.; TIMI Study Group. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur. Heart J. 2004; 25(22): 1998-2005
  7. Masoudi F.A., Plomondon M.E., Magid D.J. Renal insufficiency and mortality from acute coronary syndromes. Am. Heart J. 2004; 147(4): 623-629
  8. InTIME-II Investigators. Intravenous NPA for the treatment of infracting myocardium early: InTIME II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur. Heart J. 2000; 21(24): 2005-2013
  9. Tessone A., Gottlieb S., Barbash I.M. et al. Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology. 2007; 108(3): 193-199
  10. Han J.H., Chandra A., Mulgund J. et al. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am. J. Med. 2006; 119(3): 248-254
  11. Santopinto J.J., Fox K.A., Goldberg R.J. et al.; GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003; 89(9): 1003-1008
  12. Elsayed E.F., Tighiouart H., Griffith J. et al. Cardiovascular Disease and Subsequent Kidney Disease Arch Intern Med. 2007;167:1130-1136
  13. Mehran R., Nikolsky E., Lansky A.J. et al. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. J.A.C.C Cardiovasc Interv. 2009; 2(8): 748-757
  14. Medalion B., Cohen H., Assali A. et al. The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2010; 139(6): 1539-1544
  15. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984; 26: 861-868.
  16. Manttari M, Tiula E, Alikoski T et al. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-675.
  17. Fliser D, Franek E, Joest M et al. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-1204.
  18. Krop JS, Coresh J, Chambless LE et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 1999;159:1777-1783
  19. Efendigil M.C., Harley A., Deegan T., McKendrick C.S. Changes in glomerular filtration rate following myocardial infarction. Cardiovasc. Res. 1975; 9(6): 741-744
  20. Shusterman N, Strom BL, Murray TG et al. Risk factors and outcome of hospital-acquired acute renal failure: clinical epidemiologic study. Am J Med. 1987; 83(1):65-71.
  21. Liano F, Pascual J; Madrid Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int. 1996;50(3):811-818.
  22. Waikar SS, Curhan GC, Wald R et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol. 2006; 17(4):1143-1150
  23. Chronopoulos A., Cruz D.N., Ronco C. Hospital-acquired acute kidney injury in the elderly. Nat. Rev. Nephrol. 2010; 6(3): 141-149
  24. Kuitunen A., Vento A., Suojaranta-Ylinen R., Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006; 81(2): 542-546
  25. Hockman J.S., Sleeper L.A., Webb J.G. et al for the SHOCK investigators: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N. Engl. J. Med. 1999; 341:625-634
  26. Koreny M., Delle Karth G., Geppert A. et al Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 2002; 112:115-119
  27. Parikh С.R., Coca S.G. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008;168(9):987-995
  28. Hasdai D., Holmes D.R., Califf R.M. et al. Cardiogenic shock complicating acute myocardial infarction: Predictors of death. Am Heart J 1999; 138: 21-31
  29. Thakar C.V., Worley S., Arrigain S. et al. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005;67(3):1112-1119
  30. Forman D.E., Butler J., Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-67.
  31. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605.
  32. Мухин Н.А. Снижение скорости клубочковой фильтрации - общепопуляционный маркер неблагоприятного прогноза. Тер архив. 2007; 6: 5-10
  33. Abuelo G.J. Normotensive ischemic acute renal failure. N Engl J Med. 2007; 357: 797-805
  34. Modi K.S., Rao V.K. Atheroembolic renal disease. J. Am. Soc. Nephrol. 2001; 12: 1781 - 1787
  35. Moss N.G., Colinders R.E., Gottschalk C.W. Neural control of renal function. In Windhager E.E. (ed.) Renal physiology NY, Oxford University Press 1992
  36. Videbaek J., Christensen N.J., Sterndorff B. Serial determination of plasma catecholamines in myocardial infarction. Circulation. 1972; 46(5): 846-855
  37. McKenna O.C., Angelakos E.T. Adrenergic innervation of the canine kidney. Circ. Res. 1968; 22(3): 345-354
  38. Makita Y. Effects of adrenoceptor agonists and antagonists on smooth muscle cells and neuromuscular transmission in the guinea-pig renal artery and vein. Br. J. Pharmacol. 1983; 80(4): 671-679
  39. Cohn J.N., Khatri I.M., Hamosh P. Bedside catheterization of the left ventricle. Am. J. Cardiol. 1970; 25(1): 66-69
  40. Pichet R., Cantin M., Thibault G. et al. Hemodynamic and renal responses in physiological levels of ANF in conscious dog. J. Hypertens. 1989; 14: 104-110
  41. Gaillard C.A., Mizelle H.L., Mantani J.P. et al. ANF and blood pressure control: role of sodium and aldosterone. Am J Physiol 1990; 259: R973-R980
  42. Bongartz, L.G <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Bongartz%20LG%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>., Cramer M.J., Doevendans P.A. et al. The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J. <javascript:AL_get(this,%20'jour',%20'Eur%20Heart%20J.');> 2005; 26(1): 11-17
  43. Liu P.P. Cardiorenal syndrome in heart failure: a cardiologist's perspective. Can. J. Cardiol. 2008; 24 Suppl B: 25B-29B
  44. Bellomo R., Kellum J.A., Mehta R. et al. Acute Dialysis Quality Initiative II: the Vicenza conference. Curr. Opin. Crit. Care. 2002; 8(6): 505-508
  45. Goldberg A., Hammerman H., Petcherski S. et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am. Heart J. 2005; 150: 330-337
  46. Li W.X <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Li%20WX%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Chen H.D <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Chen%20HD%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Wnag X.W. et al. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Chin. Med. J. (Engl.). <javascript:AL_get(this,%20'jour',%20'Chin%20Med%20J%20(Engl).');> 2009; 122(9): 1020-1025
  47. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 2008; 73(5): 538-546
  48. Deinum J., Derkx F.H. Cystatin for estimation of glomerular filtration rate? Lancet 2000; 356: 1624-1625 <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11089817&dopt=Abstract>
  49. Thomas L., Huber A.R. Renal function - estimation of glomerular filtration rate. Clin. Chem. Lab. Med. 2006; 44(11): 1295-1302
  50. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002; 40: 221-226
  51. Parikh C.R., Mishra J., Thiessen-Philbrook H. et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery <http://www.ncbi.nlm.nih.gov/pubmed/16710348?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum>. Kidney Int. 2006; 70(1): 199-203.
  52. Mishra J., Dent C., Tarabishi R. et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet. 2005; 365: 1231-1238
  53. Windt W.A., Eijkelkamp W.B., Henning R.H. et al. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. J. Am. Soc. Nephrol. 2006; 17(11): 3059-3066
  54. Dragu R, Hammerman H. ST elevation myocardial infarction and renal impairment. Does it matter how we reperfuse? Acute Card Care. 2007; 9(1):22-24
  55. The ESC Task Force. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur. Heart J. 2004; 25: Р. 1454-1470
  56. Hillege H.L., van Gilsta W.H., van Veldhuisen D.J. et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur. Heart J. 2003; 24: 412-420
  57. Van Praet J.T, De Vriese A.S. Prevention of contrast-induced nephropathy: a critical review. Curr. Opin. Nephrol. Hypertens. 2007; 16(4): 336-347
  58. Krug H., Raszeja-Wanic B ., Wochowiak A et al. Intravascular coagulation in acute renal failure after myocardial infarction. Ann. Int. Med. 1974; 81: 494-497
  59. Yusuf S., Mehta S.R., Chrolavicius S. et al. Fifth Organisation to Assess Strategies in Acute Ischaemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndrome. N. Engl. J. Med. 2006; 354(14): 1464-1476
  60. Medi C., Montalescot G., Budaj A. et al. et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (global registry of acute coronary events). J.A.C.C. Cardiovasc. Interv. 2009; 2: 26-33
  61. Latif F., Kleiman N., Cohen D.J. et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc. Interv. 2009; 2, 37-45
  62. Charytan D., Mauri L., Agarwal A. et al. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am. Heart J. 2006;152:558-564
  63. Herzog CA. Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome? Nephrol. Dial. Transpl. 2002;17: 7-10.
  64. Dragu R., Behar S., Sandach A. et al. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am. J. Cardiol. 2006; 97: 1142-1145
  65. Keeley E.C., Kadakia R., Soman S. et al. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am. J. Cardiol 2003; 92:509 -514

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies